Mingxi Yue
State Key Laboratory Of Vaccines For Infectious Diseases
Xiamen, 361102, China
Xiamen, 361102, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Development of COVID-19 Vaccine Candidates Using Attenuated Recombinant Vesicular Stomatitis Virus Vectors with M Protein Mutations.
Journal: Viruses
Published: May 23, 2025
An engineered VSV-vectored rabies vaccine with an RABV-G-L71S mutation.
Journal: iScience
Published: March 01, 2025
Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects.
Journal: Signal transduction and targeted therapy
Published: August 24, 2023
Micronanoparticled risedronate exhibits potent vaccine adjuvant effects.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 14, 2023
The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 16, 2022
A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters.
Journal: Science translational medicine
Published: December 11, 2020
SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.
Journal: Emerging microbes & infections
Published: September 08, 2020
Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal.
Journal: Journal of pharmaceutical analysis
Published: February 10, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026